Back to Search Start Over

Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.

Authors :
Koda K
Toyoshima M
Nozue T
Suda T
Source :
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Aug 15; Vol. 59 (16), pp. 2015-2021. Date of Electronic Publication: 2020 May 08.
Publication Year :
2020

Abstract

A 69-year-old woman presented with appetite loss, fatigue, and a low-grade fever. She had been receiving certolizumab pegol for rheumatoid arthritis for six years. Computed tomography of the chest showed multiple micronodules in both lungs and bilateral hilar and mediastinal lymphadenopathy. An ophthalmic examination showed the findings of uveitis. Lymphocytosis with an increased CD4/CD8 ratio was seen in the bronchoalveolar lavage fluid. Video-assisted thoracoscopic biopsy specimens obtained from the right lung and a right hilar lymph node showed noncaseous epithelioid cell granulomas. Anti-tumor necrosis factor-α-induced sarcoidosis was diagnosed, and she was successfully treated with cessation of certolizumab pegol and systemic corticosteroid therapy.

Details

Language :
English
ISSN :
1349-7235
Volume :
59
Issue :
16
Database :
MEDLINE
Journal :
Internal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
32389943
Full Text :
https://doi.org/10.2169/internalmedicine.4275-19